MODIFIZIERTE PHOSPHATASEN

European patent · EP2155866 · In force

Register entry

Publication number
EP2155866
Application number
EP08741670
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 25, 2008
Published
Feb 24, 2010
Granted
Nov 29, 2017
Protection ends at the latest
Apr 24, 2028
Next annual fee due
Apr 30, 2027
IPC classes
C12N 9/16 (2006.01)
C12N 15/52 (2006.01)
C12N 15/85 (2006.01)
A61K 38/00 (2006.01)
Priority
EP 07107176 27.04.2007
US 926695 P 27.04.2007
PCT application
PCT/NL2008/050249 25.04.2008
PCT publication
WO2008/133511 06.11.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jun 19, 2020

    Address changed

    Owner
    AM-Pharma B.V., Rumpsterweg 6, 3981 AK Bunnik, Netherlands → AM-Pharma B.V., Stadsplateau 6, 3521 AZ Utrecht, Netherlands

    Published in Swissreg on 19.06.2020

  6. Nov 29, 2017

    Granted

    Published in Swissreg on 29.11.2017

Parties

Holder

AM-Pharma B.V.

Stadsplateau 6, 3521 AZ Utrecht, NL

Inventor

VELDERS, Markwin Paul

NL-1217 ED Hilversum, NL

JONK, Luigi Johannes Cornelius

NL-3571 BC Utrecht, NL

RAABEN, Willem

NL-3824 NW Amersfoort, NL

WULFERINK, Marty Bernardus Fransiscus

NL-6717 JE Ede, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.